Quick Update for SeqLL (SQL) Investors

By Blake Campbell • Tuesday, May 30 15:03 • Permanent Link

Shares of Small-cap health care company SeqLL moved -23.6 this afternoon, and are now trading at $0.4 per share. On the other hand, the average analyst target price for the stock is $3.0.

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide.

SeqLL Investors Should Consider This:

SeqLL has moved -29.2% over the last year.
Its Price to Book (P/B) ratio is 1.31

Understanding SeqLL's Operating Margins

Date Reported	Total Revenue ($ k)	Operating Expenses ($ k)	Operating Margins (%)	YoY Growth (%)
2022-12-31	1	3,998	-339605	-6298.8
2021-12-31	48	2,539	-5307.32	-182.7
2020-12-31	51	830	-1877.37	-31.49
2019-12-31	160	2,232	-1427.78	n/a

Averaging out to -87054.3% over the last 4 years, SeqLL's operating margins also have a high coefficient of variability, which stands at 193.4%. The firm's margins are declining at a -292.7% compounded yearly rate.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.